稲熊 大城

Medicine & Life Sciences

1. Dialysis 100%
2. Chronic Renal Insufficiency 64%
3. Cohort Studies 44%
4. Mortality 40%
5. Kidney 34%
6. Prospective Studies 28%
7. Japan 27%
8. Antineutrophil Cytoplasmic Antibodies 25%
9. Glomerular Filtration Rate 24%
10. Serum 23%
11. Calcitriol Receptors 21%
12. Renal Dialysis 20%
13. Chronic Kidney Failure 20%
14. continuous erythropoietin receptor activator 20%
15. Vasculitis 18%
16. Hemoglobins 16%
17. Multicenter Studies 12%
18. Cardiovascular Diseases 12%
19. Kidney Transplantation 12%
20. Creatinine 11%
21. Immunoglobulin A 11%
22. Observational Studies 10%
23. Maintenance 10%
24. Incidence 10%
25. Diet Therapy 9%
26. alfacalcidol 9%
27. Peritoneal Dialysis 9%
28. Aortic Valve Stenosis 9%
29. Secondary Hyperparathyroidism 9%
30. Biopsy 9%
31. Anemia 9%
32. Erythropoietin 9%
33. Confidence Intervals 9%
34. Glomerulonephritis 8%
35. Iron 8%
36. Vitamin D 8%
37. Therapeutics 8%
38. Phosphates 8%
39. Proteinuria 7%
40. Nephrology 7%
41. Parathyroid Hormone 7%
42. Recurrence 7%
43. 1,25-dihydroxyvitamin D 7%
44. Nephrologists 7%
45. Hematinics 7%
46. Renin-Angiotensin System 7%
47. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 7%
48. Blood Component Removal 7%
49. Retrospective Studies 6%
50. Transplants 6%